TY - JOUR
T1 - IL-5 links adaptive and natural immunity in reducing atherosclerotic disease
AU - Daugherty, Alan
AU - Rateri, Debra L.
AU - King, Victoria L.
PY - 2004/8
Y1 - 2004/8
N2 - Oxidized LDL induces changes in several facets of the immune system, although the relationships between these facets and their contributions to atherogenesis have yet to be fully elucidated. A report in this issue of the JCI provides a novel demonstration of the adaptive immune system influencing the production of natural antibodies. The results demonstrate that injection of malondialdehyde-modified LDL promotes a Th2 response that in turn increases the titers of the natural antibody T15/EO6, which recognizes the oxidized phospholipid POVPC. Atherosclerotic lesion size in LDL receptor-deficient mice is reduced as a consequence of the increase in natural antibody titers, and IL-5 is identified as the link between the adaptive and natural immune systems (see related article beginning on page 427).
AB - Oxidized LDL induces changes in several facets of the immune system, although the relationships between these facets and their contributions to atherogenesis have yet to be fully elucidated. A report in this issue of the JCI provides a novel demonstration of the adaptive immune system influencing the production of natural antibodies. The results demonstrate that injection of malondialdehyde-modified LDL promotes a Th2 response that in turn increases the titers of the natural antibody T15/EO6, which recognizes the oxidized phospholipid POVPC. Atherosclerotic lesion size in LDL receptor-deficient mice is reduced as a consequence of the increase in natural antibody titers, and IL-5 is identified as the link between the adaptive and natural immune systems (see related article beginning on page 427).
UR - http://www.scopus.com/inward/record.url?scp=4043102054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4043102054&partnerID=8YFLogxK
U2 - 10.1172/JCI200422561
DO - 10.1172/JCI200422561
M3 - Review article
C2 - 15286796
AN - SCOPUS:4043102054
SN - 0021-9738
VL - 114
SP - 317
EP - 319
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -